The proposal process
The Sanford Data Collaborative supports projects that encompass our research priority areas. These areas have been selected as key to driving health care delivery forward:
- Patient Satisfaction:Priority area focuses on innovative analytics to examine health care satisfaction data (open-text and discrete variable data available), looking to predict health care utilization, patient engagement or other utilization/outcomes data.
- Risk Stratification: Priority area focuses on algorithmic development to improve patient segmentation by targeting rising and at-risk patients based on patient characteristics and behaviors leading to inappropriate vs. appropriate health care utilization.
- Pre-test Probability: Over-testing is a significant burden to patients and cost to health care systems. This priority area focuses on algorithm development to identify pre-test characteristics predictive of patient testing outcomes targeted at high cost laboratory and imaging studies.
- Open Innovation: Innovative projects with a priority not identified above are welcome. Proposals should be discussed with the data collaborative director in advance to ensure data availability and alignment with health care priorities.
Proposal and project timeline
- Proposal Information Webinar: Thursday, Sept. 7, 12-1pm.
- Applications due: Friday, Oct. 6, 2017
- Award notification and data release: November 2017
- Data analysis phase: December 2017 – May 2018
- Feasibility and validation phase: Begins June 2018
Sanford is committed to the protection of our patient’s data. Datasets will be limited in nature, researchers and their associated academic institutions will be required to sign a Data Usage Agreement ensuring the highest level of protection surrounding released data.
The data comes from Sanford Health, one of the largest health care systems in the nation. Headquartered in the Dakotas, the system has received nearly $1 billion in gifts from philanthropist Denny Sanford. These gifts have allowed for several groundbreaking initiatives, including global children's clinics, genomic medicine and specialized centers researching cures for type 1 diabetes, breast cancer and other diseases.